Search clinical trials for: Ofatumumab plus Dacarbazine
Total 5136 results
-
Medical University of ViennaCompletedStage IV Melanoma | Stage III MelanomaAustria
-
Genta IncorporatedCompletedMelanomaUnited States, France, United Kingdom, Spain, Switzerland, Australia, Canada, Germany, Poland, Italy, Austria, Czech Republic
-
Simcere Pharmaceutical Co., LtdUnknownAdvanced Melanoma | Untreated PatientsChina
-
Istituto Superiore di SanitàUniversity of Rome Tor Vergata; Regina Elena Cancer InstituteCompleted
-
University of ZurichCompletedMelanoma Stage III or IV | No Prior ChemotherapySwitzerland
-
GlaxoSmithKlineCompletedMultiple SclerosisUnited States, Bulgaria, Russian Federation, Spain, Germany, Czechia, Netherlands, Norway, Italy, Canada, Denmark
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineTerminatedArthritis, RheumatoidUnited States, Denmark, Hungary, United Kingdom, Poland
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, Chronic and Lymphoma, FollicularJapan
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, Chronic
-
Novartis PharmaceuticalsCompleted
-
Fondazione Italiana Linfomi ONLUSCompletedFollicular Lymphoma, Grade 1 | Follicular Lymphoma, Grade 2 | Follicular Lymphoma Grade 3AItaly
-
Novartis PharmaceuticalsRecruitingMultiple Sclerosis (MS)France
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruitingLeukemia, Lymphoblastic, ChronicItaly
-
Mahidol UniversityUnknown
-
Massachusetts General HospitalGlaxoSmithKline; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical...CompletedFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic LymphomaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedRelapsed or Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Austria, Belgium, France, Ireland, Italy, Poland, Spain, United Kingdom
-
Michael John RobertsonNovartisCompletedNon-Hodgkin's LymphomaUnited States
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisAustralia
-
Joseph TuscanoGlaxoSmithKlineCompletedChronic Lymphocytic LeukemiaUnited States
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicKorea, Republic of, Japan
-
VicalCompletedRecurrent Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
Brno University HospitalFaculty Hospital Kralovske Vinohrady; University Hospital Hradec Kralove; General...CompletedChronic Lymphocytic LeukemiaCzech Republic
-
Pharmacyclics LLC.Ohio State UniversityCompletedB-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter's Transformation | Prolymphocyctic LeukemiaUnited States
-
University Health Network, TorontoNovartisCompletedChronic Lymphocytic Leukemia (CLL)Canada
-
Novartis PharmaceuticalsRecruiting
-
Novartis PharmaceuticalsCompletedMultiple SclerosisUnited States, Austria, Spain, Czechia, Estonia, Bulgaria, Latvia, Lithuania, Russian Federation
-
Brown UniversityThe Miriam Hospital; Dartmouth-Hitchcock Medical Center; Rhode Island Hospital; Memorial Hospital of Rhode IslandTerminatedLymphoma, Non-HodgkinsUnited States
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationCompletedMelanomaAustralia, United States
-
GlaxoSmithKlineTerminatedArthritis, RheumatoidPoland, Russian Federation, Argentina, Belgium, Peru, Spain, Australia, Czechia, South Africa, Chile, Hungary, United Kingdom, Romania
-
GlaxoSmithKlineCompletedArthritis, RheumatoidRussian Federation, Australia, Belgium, Spain, United States, New Zealand, Italy, Poland, France
-
GlaxoSmithKlineCompleted
-
Januario Castro, M.D.GlaxoSmithKlineCompleted
-
Nevada Cancer InstituteGlaxoSmithKline; CephalonWithdrawnChronic Lymphocytic Leukemia (CLL)United States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbCompleted
-
Philogen S.p.A.Eudax S.r.l.TerminatedMetastatic MelanomaSwitzerland, Italy, Austria, Germany
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedChronic Graft Versus Host DiseaseUnited States
-
National Cancer Institute (NCI)CompletedIris Melanoma | Stage IV Uveal Melanoma | Medium/Large Size Posterior Uveal Melanoma | Recurrent Uveal Melanoma | Ocular Melanoma With Extraocular Extension | Small Size Posterior Uveal MelanomaUnited States, Canada
-
University of CologneCompleted
-
GlaxoSmithKlineCompletedLymphoma, Large-Cell, DiffuseUnited Kingdom
-
National Cancer Institute (NCI)ExelisisCompletedStage IV Uveal Melanoma AJCC v7 | Recurrent Uveal Melanoma | Stage III Uveal Melanoma AJCC v7 | Stage IIIA Uveal Melanoma AJCC v7 | Stage IIIB Uveal Melanoma AJCC v7 | Stage IIIC Uveal Melanoma AJCC v7United States, Canada
-
Novartis PharmaceuticalsCompleted
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedWaldenström MacroglobulinemiaUnited States
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompletedMantle Cell LymphomaUnited States
-
GlaxoSmithKlineCompletedWaldenstrom MacroglobulinaemiaUnited States
-
University of Erlangen-Nürnberg Medical SchoolWuerzburg University Hospital; University Hospital RegensburgRecruiting
-
National Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Nevada Cancer InstituteGlaxoSmithKline; CephalonTerminatedChronic Lymphocytic Leukemia (CLL)United States